Which of the following statements is NOT TRUE about Tacrolimus?
**Core Concept**
Tacrolimus is a calcineurin inhibitor immunosuppressant used primarily in organ transplantation to prevent rejection. It works by inhibiting the calcineurin pathway, which is crucial for T-cell activation and proliferation.
**Why the Correct Answer is Right**
Tacrolimus binds to FKBP-12 (FK506 binding protein), a cytosolic protein, and this complex inhibits the phosphatase activity of calcineurin. This inhibition prevents the dephosphorylation of NFAT (nuclear factor of activated T-cells), which is essential for the transcription of IL-2 and other cytokines involved in the immune response. By blocking this pathway, tacrolimus suppresses the immune response and prevents graft rejection.
**Why Each Wrong Option is Incorrect**
**Option A:** Tacrolimus is a prodrug that requires metabolic activation to its active form. This statement is **TRUE**.
**Option B:** Tacrolimus is metabolized primarily by the liver enzyme CYP3A4. This statement is **TRUE**.
**Option C:** Tacrolimus causes nephrotoxicity as a side effect. This statement is **TRUE**.
**Clinical Pearl / High-Yield Fact**
Tacrolimus has a narrow therapeutic index and requires close monitoring of blood levels to avoid toxicity. Patients on tacrolimus should be advised to avoid grapefruit juice, as it can increase tacrolimus levels.
**Correct Answer: D. There is no option D listed. Please provide the correct options A, B, C, D.**